The compassionate use poll: A lopsided vote favors posting policies, with plenty of fretting
We ran a snap poll yesterday on compassionate use policies, and there’s clearly plenty of positive sentiment among our readers backing some sort of easily accessible, online statement explaining each biotech’s policies on expanded access to experimental drugs.
The vote landed 70% for, 30% against posting a compassionate use policy online among the 149 votes we collected in the last 24 hours. But maybe that has a lot to do with the fact that a very similar sized group also said that such policy statements don’t apply to their companies. Among the 49 who said it did apply, 33 said their companies didn’t post a policy, against 16 who said they did.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.